Loss of $\alpha$-hemoglobin–stabilizing protein impairs erythropoiesis and exacerbates $\beta$-thalassemia. Kong, Y., Zhou, S., Kihm, A. J., Katein, A. M., Yu, X., Gell, D. A., Mackay, J. P., Adachi, K., Foster-Brown, L., Louden, C. S., Gow, A. J., & Weiss, M. J. Journal of Clinical Investigation, 114(10):1457–1466, nov, 2004. Paper doi abstract bibtex Hemoglobin (Hb) A production during red blood cell development is coordinated to minimize the deleterious effects of free alpha- and beta-Hb subunits, which are unstable and cytotoxic. The alpha-Hb-stabilizing protein (AHSP) is an erythroid protein that specifically binds alpha-Hb and prevents its precipitation in vitro, which suggests that it may function to limit free alpha-Hb toxicities in vivo. We investigated this possibility through gene ablation and biochemical studies. AHSP(-/-) erythrocytes contained hemoglobin precipitates and were short-lived. In hematopoietic tissues, erythroid precursors were elevated in number but exhibited increased apoptosis. Consistent with unstable alpha-Hb, AHSP(-/-) erythrocytes contained increased ROS and evidence of oxidative damage. Moreover, purified recombinant AHSP inhibited ROS production by alpha-Hb in solution. Finally, loss of AHSP worsened the phenotype of beta-thalassemia, a common inherited anemia characterized by excess free alpha-Hb. Together, the data support a model in which AHSP binds alpha-Hb transiently to stabilize its conformation and render it biochemically inert prior to Hb A assembly. This function is essential for normal erythropoiesis and, to a greater extent, in beta-thalassemia. Our findings raise the possibility that altered AHSP expression levels could modulate the severity of beta-thalassemia in humans.
@article{Kong2004,
abstract = {Hemoglobin (Hb) A production during red blood cell development is coordinated to minimize the deleterious effects of free alpha- and beta-Hb subunits, which are unstable and cytotoxic. The alpha-Hb-stabilizing protein (AHSP) is an erythroid protein that specifically binds alpha-Hb and prevents its precipitation in vitro, which suggests that it may function to limit free alpha-Hb toxicities in vivo. We investigated this possibility through gene ablation and biochemical studies. AHSP(-/-) erythrocytes contained hemoglobin precipitates and were short-lived. In hematopoietic tissues, erythroid precursors were elevated in number but exhibited increased apoptosis. Consistent with unstable alpha-Hb, AHSP(-/-) erythrocytes contained increased ROS and evidence of oxidative damage. Moreover, purified recombinant AHSP inhibited ROS production by alpha-Hb in solution. Finally, loss of AHSP worsened the phenotype of beta-thalassemia, a common inherited anemia characterized by excess free alpha-Hb. Together, the data support a model in which AHSP binds alpha-Hb transiently to stabilize its conformation and render it biochemically inert prior to Hb A assembly. This function is essential for normal erythropoiesis and, to a greater extent, in beta-thalassemia. Our findings raise the possibility that altered AHSP expression levels could modulate the severity of beta-thalassemia in humans.},
annote = {cited By 110},
author = {Kong, Yi and Zhou, Suiping and Kihm, Anthony J. and Katein, Anne M. and Yu, Xiang and Gell, David A. and Mackay, Joel P. and Adachi, Kazuhiko and Foster-Brown, Linda and Louden, Calvert S. and Gow, Andrew J. and Weiss, Mitchell J.},
doi = {10.1172/JCI21982},
issn = {0021-9738},
journal = {Journal of Clinical Investigation},
month = {nov},
number = {10},
pages = {1457--1466},
pmid = {15545996},
title = {{Loss of $\alpha$-hemoglobin–stabilizing protein impairs erythropoiesis and exacerbates $\beta$-thalassemia}},
url = {http://www.ncbi.nlm.nih.gov/pubmed/15545996},
volume = {114},
year = {2004}
}
Downloads: 0
{"_id":"dNPTwRnZERLsappHL","bibbaseid":"kong-zhou-kihm-katein-yu-gell-mackay-adachi-etal-lossofalphahemoglobinstabilizingproteinimpairserythropoiesisandexacerbatesbetathalassemia-2004","authorIDs":["ZTncL5PqZZ6RafCsL"],"author_short":["Kong, Y.","Zhou, S.","Kihm, A. J.","Katein, A. M.","Yu, X.","Gell, D. A.","Mackay, J. P.","Adachi, K.","Foster-Brown, L.","Louden, C. S.","Gow, A. J.","Weiss, M. J."],"bibdata":{"bibtype":"article","type":"article","abstract":"Hemoglobin (Hb) A production during red blood cell development is coordinated to minimize the deleterious effects of free alpha- and beta-Hb subunits, which are unstable and cytotoxic. The alpha-Hb-stabilizing protein (AHSP) is an erythroid protein that specifically binds alpha-Hb and prevents its precipitation in vitro, which suggests that it may function to limit free alpha-Hb toxicities in vivo. We investigated this possibility through gene ablation and biochemical studies. AHSP(-/-) erythrocytes contained hemoglobin precipitates and were short-lived. In hematopoietic tissues, erythroid precursors were elevated in number but exhibited increased apoptosis. Consistent with unstable alpha-Hb, AHSP(-/-) erythrocytes contained increased ROS and evidence of oxidative damage. Moreover, purified recombinant AHSP inhibited ROS production by alpha-Hb in solution. Finally, loss of AHSP worsened the phenotype of beta-thalassemia, a common inherited anemia characterized by excess free alpha-Hb. Together, the data support a model in which AHSP binds alpha-Hb transiently to stabilize its conformation and render it biochemically inert prior to Hb A assembly. This function is essential for normal erythropoiesis and, to a greater extent, in beta-thalassemia. Our findings raise the possibility that altered AHSP expression levels could modulate the severity of beta-thalassemia in humans.","annote":"cited By 110","author":[{"propositions":[],"lastnames":["Kong"],"firstnames":["Yi"],"suffixes":[]},{"propositions":[],"lastnames":["Zhou"],"firstnames":["Suiping"],"suffixes":[]},{"propositions":[],"lastnames":["Kihm"],"firstnames":["Anthony","J."],"suffixes":[]},{"propositions":[],"lastnames":["Katein"],"firstnames":["Anne","M."],"suffixes":[]},{"propositions":[],"lastnames":["Yu"],"firstnames":["Xiang"],"suffixes":[]},{"propositions":[],"lastnames":["Gell"],"firstnames":["David","A."],"suffixes":[]},{"propositions":[],"lastnames":["Mackay"],"firstnames":["Joel","P."],"suffixes":[]},{"propositions":[],"lastnames":["Adachi"],"firstnames":["Kazuhiko"],"suffixes":[]},{"propositions":[],"lastnames":["Foster-Brown"],"firstnames":["Linda"],"suffixes":[]},{"propositions":[],"lastnames":["Louden"],"firstnames":["Calvert","S."],"suffixes":[]},{"propositions":[],"lastnames":["Gow"],"firstnames":["Andrew","J."],"suffixes":[]},{"propositions":[],"lastnames":["Weiss"],"firstnames":["Mitchell","J."],"suffixes":[]}],"doi":"10.1172/JCI21982","issn":"0021-9738","journal":"Journal of Clinical Investigation","month":"nov","number":"10","pages":"1457–1466","pmid":"15545996","title":"Loss of $\\alpha$-hemoglobin–stabilizing protein impairs erythropoiesis and exacerbates $\\beta$-thalassemia","url":"http://www.ncbi.nlm.nih.gov/pubmed/15545996","volume":"114","year":"2004","bibtex":"@article{Kong2004,\nabstract = {Hemoglobin (Hb) A production during red blood cell development is coordinated to minimize the deleterious effects of free alpha- and beta-Hb subunits, which are unstable and cytotoxic. The alpha-Hb-stabilizing protein (AHSP) is an erythroid protein that specifically binds alpha-Hb and prevents its precipitation in vitro, which suggests that it may function to limit free alpha-Hb toxicities in vivo. We investigated this possibility through gene ablation and biochemical studies. AHSP(-/-) erythrocytes contained hemoglobin precipitates and were short-lived. In hematopoietic tissues, erythroid precursors were elevated in number but exhibited increased apoptosis. Consistent with unstable alpha-Hb, AHSP(-/-) erythrocytes contained increased ROS and evidence of oxidative damage. Moreover, purified recombinant AHSP inhibited ROS production by alpha-Hb in solution. Finally, loss of AHSP worsened the phenotype of beta-thalassemia, a common inherited anemia characterized by excess free alpha-Hb. Together, the data support a model in which AHSP binds alpha-Hb transiently to stabilize its conformation and render it biochemically inert prior to Hb A assembly. This function is essential for normal erythropoiesis and, to a greater extent, in beta-thalassemia. Our findings raise the possibility that altered AHSP expression levels could modulate the severity of beta-thalassemia in humans.},\nannote = {cited By 110},\nauthor = {Kong, Yi and Zhou, Suiping and Kihm, Anthony J. and Katein, Anne M. and Yu, Xiang and Gell, David A. and Mackay, Joel P. and Adachi, Kazuhiko and Foster-Brown, Linda and Louden, Calvert S. and Gow, Andrew J. and Weiss, Mitchell J.},\ndoi = {10.1172/JCI21982},\nissn = {0021-9738},\njournal = {Journal of Clinical Investigation},\nmonth = {nov},\nnumber = {10},\npages = {1457--1466},\npmid = {15545996},\ntitle = {{Loss of $\\alpha$-hemoglobin–stabilizing protein impairs erythropoiesis and exacerbates $\\beta$-thalassemia}},\nurl = {http://www.ncbi.nlm.nih.gov/pubmed/15545996},\nvolume = {114},\nyear = {2004}\n}\n","author_short":["Kong, Y.","Zhou, S.","Kihm, A. J.","Katein, A. M.","Yu, X.","Gell, D. A.","Mackay, J. P.","Adachi, K.","Foster-Brown, L.","Louden, C. S.","Gow, A. J.","Weiss, M. J."],"key":"Kong2004","id":"Kong2004","bibbaseid":"kong-zhou-kihm-katein-yu-gell-mackay-adachi-etal-lossofalphahemoglobinstabilizingproteinimpairserythropoiesisandexacerbatesbetathalassemia-2004","role":"author","urls":{"Paper":"http://www.ncbi.nlm.nih.gov/pubmed/15545996"},"downloads":0},"bibtype":"article","creationDate":"2020-10-01T05:32:51.853Z","downloads":0,"keywords":[],"search_terms":["loss","alpha","hemoglobin","stabilizing","protein","impairs","erythropoiesis","exacerbates","beta","thalassemia","kong","zhou","kihm","katein","yu","gell","mackay","adachi","foster-brown","louden","gow","weiss"],"title":"Loss of $\\alpha$-hemoglobin–stabilizing protein impairs erythropoiesis and exacerbates $\\beta$-thalassemia","year":2004,"biburl":"https://drive.google.com/uc?export=download&id=1EvkYjMfb1LmGOV8-ek4_e6g77kIA7ABa","dataSources":["QNo3CKhtog6c3sh7Y"]}